Medifast
MED
#9396
Rank
HK$1.12 B
Marketcap
HK$100.45
Share price
0.63%
Change (1 day)
9.56%
Change (1 year)

Operating Margin for Medifast (MED)

Operating Margin as of November 2026 (TTM): -1.46%

According to Medifast's latest financial reports and stock price the company's current Operating Margin is -1.46%. At the end of 2021 the company had an Operating Margin of 14.16%.

Operating Margin history for Medifast from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202114.16%-1.39%
202014.36%10.98%
201912.94%-8.09%
201814.08%5.3%
201713.37%35.36%
20169.88%-9.18%
201510.88%-2.09%
201411.11%15.97%
20139.58%39.71%
20126.86%-26.14%
20119.28%-24.56%
201012.31%5.63%
200911.65%56.48%
20087.44%12.52%
20076.62%-33.2%
20069.90%1.14%
20059.79%-7.86%
200410.63%-24.18%
200314.02%1.93%
200213.75%22.04%
200111.27%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
OPKO Health
OPK
-13.57% 829.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.